Combio A/S

Combio A/S was a drug discovery company dedicated to rapid identifications and optimisation of novel therapeutic candidates.

Combio was based on a proprietary platform technology in the area of “Solid Phase Combinatorial Chemistry” (“SPOC”). The SPOC technology was developed at Carlsberg Laboratories. Combio held an exclusive, worldwide license to the technology that is a powerful tool in drug discovery.

In October 2004, Combio A/S was acquired by Swiss biotech company Arpida Ltd.